Prelude Capital Management, LLC Syndax Pharmaceuticals Inc Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $226,082 - $317,128	10,943 New	10,943 $231,000
Q4 2020 Feb 16, 2021	SELL	$15.1 - $26.44 $4,530 - $7,932	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $4,017 - $5,244	300 New	300 $4,000
Q2 2018 Aug 14, 2018	SELL	$6.93 - $14.63 $498,530 - $1.05 Million	-71,938 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.71 - $14.82 $344,672 - $586,457	39,572 Added 122.26%	71,938 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $252,454 - $418,816	32,366	32,366 $284,000

231

90M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $792M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.